Population Specific Biomarkers of Human Aging: A Big Data Study Using South Korean, Canadian, and Eastern European Patient Populations: https://pubmed.ncbi.nlm.nih.gov/29340580/
Scientists around the world have been bamboozled this week by a fictitious asteroid heading toward Earth.
A group of experts from US and European space agencies attended a week-long exercise led by NASA in which they faced a hypothetical scenario: An asteroid 35 million miles away was approaching the planet and could hit within six months.
For the first time, scientists have been able to precisely map the flight path of an asteroid that landed on Earth and trace it back to its point of origin. The boulder-size fragment’s journey to our planet began 22 million years ago, according to new research.
The asteroid, known as 2018 LA, appeared like a fireball in the skies over Botswana on June 2, 2018, before breaking apart and landing in the Central Kalahari Game Reserve.
Prior to breaking up in Earth’s atmosphere, scientists determined that the asteroid was about 5 feet (1.7 meters) in diameter, weighed 12566 pounds and had been traveling at 37282 miles per hour.
Just days after Earth was hit by a coronal mass ejection (CME), it appears another blast of solar wind is due to impact Earth on Sunday; it is currently traveling at a brisk 1118, 468 mph towards the planet.
A minor G1-class Geomagnetic Storm is possible late Saturday into much of Sunday as the solar wind interacts with the Earth’s magnetic field. While the National Weather Service’s Space Weather Prediction Center has not issued any advisory for this solar wind yet, a watch or warning could be posted tomorrow for this event.
An international collaboration of astronomers led by a researcher from the Astrobiology Center and Queen’s University Belfast, and including researchers from Trinity, has detected a new chemical signature in the atmosphere of an extrasolar planet (a planet that orbits a star other than our Sun).
SpaceX and NASA are targeting Saturday, May 1 at 8:35 p.m. EDT, or 00:35 UTC on May 2, for Dragon to autonomously undock from the International Space Station (ISS) and splashdown off the coast of Florida on Sunday, May 2 at approximately 2:57 a.m. EDT, 6:57 UTC, completing its first six-month operational mission to the Station.
A series of departure burns will move Dragon away from the orbiting laboratory, followed by the vehicle jettisoning the trunk to reduce weight and mass to help save propellant for the deorbit burn. Once complete, Dragon will re-enter Earth’s atmosphere and deploy its two drogue and four main parachutes in preparation for a soft water landing.
Aboard the spacecraft will be NASA astronauts Mike Hopkins, Victor Glover, Shannon Walker, and JAXA astronaut Soichi Noguchi, who flew to the space station on Dragon six months ago when Falcon 9 launched the spacecraft from historic Launch Complex 39A (LC-39A) at Kennedy Space Center in Florida on Sunday, November 15, 2020.
Upon splashdown, the Dragon and the astronauts will be quickly recovered and returned to Cape Canaveral and Houston respectively. Once the mission is complete, Dragon will be inspected and refurbished for future human spaceflight missions.
Drugs and vaccines circulate through the vascular system reacting according to their chemical and structural nature. In some cases, they are intended to diffuse. In other cases, like cancer treatments, the intended target is highly localized. The effectiveness of a medicine —and how much is needed and the side effects it causes —are a function of how well it can reach its target.
“A lot of medicines involve intravenous injections of drug carriers,” said Ying Li, an assistant professor of mechanical engineering at the University of Connecticut. “We want them to be able to circulate and find the right place at the right time and to release the right amount of drugs to safely protect us. If you make mistakes, there can be terrible side effects.”
Li studies nanomedicines and how they can be designed to work more efficiently. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. His work harnesses the power of supercomputers to simulate the dynamics of nanodrugs in the blood stream, design new forms of nanoparticles, and find ways to control them.
Harvard’s Wyss Institute has created a new gene-editing tool that enable scientist to perform millions of genetic experiments simultaneously.
Researchers from the Harvard’s Wyss Institute for Biologically Inspired Engineering have created a new gene-editing tool that can enable scientists to perform millions of genetic experiments simultaneously. They’re calling it the Retron Library Recombineering (RLR) technique, and it uses segments of bacterial DNA called retrons that can produce fragments of single-stranded DNA.
When it comes to gene editing, CRISPR-Cas9 is probably the most well-known technique these days. It’s been making waves in the science world in the past few years, giving researchers the tool they need to be able to easily alter DNA sequences. It’s more accurate than previously used techniques, and it has a wide variety of potential applications, including life-saving treatments for various illnesses.
However, the tool has some major limitations. It could be difficult to deliver CRISPR-Cas9 materials in large numbers, which remains a problem for studies and experiments, for one. Also, the way the technique works can be toxic to cells, because the Cas9 enzyme — the molecular “scissors” in charge of cutting strands of DNA — often cuts non-target sites as well.